{
  "label": "clinical_signal_03_dx_renal_biomarker_study_014",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:dd5bbd03db31f2dc081476642fd9e4000669a2de9a4be4f3b8318649094d467b",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:c334c83f0e5586d31926bcb6e60115e9bfeccda6fed885884ee61b742c0bfe26"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:57:05.806796",
  "content": "## 2024-06-03 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 84\n- Active: 77\n- Screen Failures Cumulative: 28\n- Withdrawals Cumulative: 7\n\n### Enrollment By Cohort\n- 10mg: 19\n- 25mg: 21\n- 50mg: 22\n- 100mg: 22\n\n### Biomarkers By Cohort\n- 10mg\n  - KIM-1 (ng/ml) Mean: 2.37\n  - KIM-1 (ng/ml) SD: 0.5\n  - NGAL (ng/ml) Mean: 73.7\n  - NGAL (ng/ml) SD: 17.4\n  - Cystatin C (mg/L) Mean: 0.78\n  - Cystatin C (mg/L) SD: 0.11\n  - eGFR (ml/min) Mean: 61.9\n  - eGFR (ml/min) SD: 11.9\n  - UACR (mg/g) Mean: 72.2\n  - UACR (mg/g) SD: 25.7\n  - Serum Creatinine (mg/dl) Mean: 1.07\n  - Serum Creatinine (mg/dl) SD: 0.18\n  - Urine Protein (mg/dl) Mean: 26.2\n  - Urine Protein (mg/dl) SD: 6.9\n  - Urine Output (ml/24h) Mean: 1953\n  - Urine Output (ml/24h) SD: 327\n- 25mg\n  - KIM-1 (ng/ml) Mean: 2.46\n  - KIM-1 (ng/ml) SD: 0.46\n  - NGAL (ng/ml) Mean: 70.9\n  - NGAL (ng/ml) SD: 13.9\n  - Cystatin C (mg/L) Mean: 1.03\n  - Cystatin C (mg/L) SD: 0.13\n  - eGFR (ml/min) Mean: 54.5\n  - eGFR (ml/min) SD: 8.8\n  - UACR (mg/g) Mean: 59.7\n  - UACR (mg/g) SD: 31.7\n  - Serum Creatinine (mg/dl) Mean: 1.22\n  - Serum Creatinine (mg/dl) SD: 0.27\n  - Urine Protein (mg/dl) Mean: 18.0\n  - Urine Protein (mg/dl) SD: 6.5\n  - Urine Output (ml/24h) Mean: 1632\n  - Urine Output (ml/24h) SD: 386\n- 50mg\n  - KIM-1 (ng/ml) Mean: 2.26\n  - KIM-1 (ng/ml) SD: 0.38\n  - NGAL (ng/ml) Mean: 71.0\n  - NGAL (ng/ml) SD: 16.9\n  - Cystatin C (mg/L) Mean: 0.8\n  - Cystatin C (mg/L) SD: 0.11\n  - eGFR (ml/min) Mean: 54.1\n  - eGFR (ml/min) SD: 10.0\n  - UACR (mg/g) Mean: 70.0\n  - UACR (mg/g) SD: 15.4\n  - Serum Creatinine (mg/dl) Mean: 1.07\n  - Serum Creatinine (mg/dl) SD: 0.2\n  - Urine Protein (mg/dl) Mean: 10.1\n  - Urine Protein (mg/dl) SD: 6.8\n  - Urine Output (ml/24h) Mean: 1908\n  - Urine Output (ml/24h) SD: 307\n- 100mg\n  - KIM-1 (ng/ml) Mean: 1.43\n  - KIM-1 (ng/ml) SD: 0.43\n  - NGAL (ng/ml) Mean: 95.0\n  - NGAL (ng/ml) SD: 12.9\n  - Cystatin C (mg/L) Mean: 1.06\n  - Cystatin C (mg/L) SD: 0.15\n  - eGFR (ml/min) Mean: 57.6\n  - eGFR (ml/min) SD: 15.0\n  - UACR (mg/g) Mean: 96.7\n  - UACR (mg/g) SD: 23.8\n  - Serum Creatinine (mg/dl) Mean: 1.13\n  - Serum Creatinine (mg/dl) SD: 0.29\n  - Urine Protein (mg/dl) Mean: 12.4\n  - Urine Protein (mg/dl) SD: 3.6\n  - Urine Output (ml/24h) Mean: 1884\n  - Urine Output (ml/24h) SD: 348\n\n### Dose Response\n- KIM-1 Dose Correlation (r): 0.533\n- NGAL Dose Correlation (r): 0.255\n- eGFR Dose Correlation (r): -0.223\n- UACR Dose Correlation (r): 0.22\n\n### Safety Labs\n- Hemoglobin (g/dl) Mean: 14.1\n- Hemoglobin (g/dl) SD: 1.2\n- Hematocrit (%) Mean: 39.4\n- Hematocrit (%) SD: 3.4\n- WBC (k) Mean: 6.3\n- WBC (k) SD: 1.6\n- Platelets (k) Mean: 230\n- Platelets (k) SD: 48\n- Sodium (meq/L) Mean: 138.1\n- Sodium (meq/L) SD: 2.5\n- Potassium (meq/L) Mean: 3.9\n- Potassium (meq/L) SD: 0.3\n- Bicarbonate (meq/L) Mean: 23.7\n- Bicarbonate (meq/L) SD: 2.7\n- Phosphorus (mg/dl) Mean: 3.1\n- Phosphorus (mg/dl) SD: 0.8\n\n### Adverse Events\n- AE ID: RB-AE-1419\n  - Description: urinary tract infection\n  - Grade: 1\n  - Relatedness: not related\n  - Resolved: true\n  - Cohort: 100mg\n- AE ID: RB-AE-1472\n  - Description: peripheral edema\n  - Grade: 2\n  - Relatedness: not related\n  - Resolved: true\n  - Cohort: 25mg\n\n### Protocol Deviations\n- None\n\n### Events\n- Drug supply reconciliation completed at 21 sites\n- Bioanalytical lab shipment: 58 frozen urine aliquots dispatched\n\n### Notes\n- Week 14: Renal biomarker collection on schedule. 84 subjects enrolled across 4 cohorts. eGFR and urinary biomarkers within expected variability.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "renal_biomarker_study",
    "theme_index": 0,
    "local_index": 14,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "b39286bd69ab4fc400a914137914eaa7bda71068fc11fdf31fc1054c8fc775f5",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "e1e99cb871eaf7b9"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}